Study of Common Cold Reveals New Treatment Targets

Today, scientists from Procter & Gamble (P&G), the University of Calgary and the University of Virginia announced results from the first study to examine the entire human genome's response to the most common cold virus, human rhinovirus. The research confirmed, at the genomic level, that the immune system response to the virus, and not the virus by itself, results in common cold symptoms. Data generated by the study will be crucial in the search for new treatments for the common cold, which is the most common illness worldwide, affecting billions of people every year. Specifically, the study identifies several categories of therapeutic targets that could balance the immune response in order to minimize symptoms during an infection and potentially even lead to therapies that may prevent infection. Results of the study are published in today's online edition of the November 1 issue of the American Journal of Respiratory and Critical Care Medicine (AJRCCM).

To view Multimedia News Release, go to http://www.prnewswire.com/mnr/procterandgamble/35537/

1. By: MultiVu
2. Categories News & Events
3. Views 321
4. Added :27-Oct-08
   Report This Video